We are confident that the expansion of Wegovy to a pill will help patients who may have not sought or accepted treatment before," said Dave Moore, Executive Vice President, US Operations at Novo Nordisk
Optimizing Endpoints for GLP-1 RA Clinical Trial Success Empowering Patient-Centric Research in Obesity, Diabetes, and Cardiovascular Health As GLP-1 receptor agonists (GLP-1 RAs) revolutionize the treatment landscape for obesity, diabetes, and related cardiovascular complications, Signant leads the way in capturing critical patient-reported outcomes (PROs) data
J Inherit.Metab Dis 2010;33(5):555-561
Collectively, numerous retrospective and large database studies have identified potential benefits of GLP-1RA in ocular disease, indicating a need for prospective trials to more definitively identify protective effects and integrate this medication class into the ophthalmology toolbox
This makes it slightly cheaper than compounded GLP-1 medications but far more expensive than individual supplements purchased separately